Enhanced spasticity in primary progressive MS patients treated with interferon beta-1b.
Frese
A
A
Bethke
F
F
Lüdemann
P
P
Stögbauer
F
F
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D018450:Disease Progression; D006801:Humans; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D009128:Muscle Spasticity / Q000139:chemically induced*
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a